NFKB1 and lung carcinoma: Dihydroartemisinin-triggered ferroptosis of TAMs lead to DNA damage and activation of the NF-κB signaling pathway to reprogram TAMs to an M1-like type, thus providing a new approach for lung cancer therapy.